Входя на эту страницу, Вы подтверждаете, что являетесь  медицинским работником.

Status message

Not the entire site translated, but only to "Journal"

Treatment Optimization of Depression in Elderly Patients in a Psychiatric Hospital

T.P. Safarova,O.B. Yakovleva,S.I.Gavrilova

Federal State Budget Scientific Institution“Mental Health Research Center”, Moscow, Russia

SUMMARY.
Objective: Development of methods for increasing the effectiveness of antidepressant therapy in a gerontopsychiatric hospital by including drugs with neuro-metabolic and neuroprotective properties in the treatment regimen of elderly patients with depressive disorders.

Material and methods: 152 elderly in-patients (60 years and older) with different forms of depressive episodes in according to ICD-10 were treated with two types of antidepressant therapy for 56 days. The first group of patients (44 patients) received monotherapy by one of the new generation antidepressants (fluvoxamine, venlafaxine or agomelatine) The secondgroup of 108 patients received complex therapy with one of the same antidepressants in combination with one of the neuroprotective drugs (cerebrolysin, carnitine, citicoline, ethylmethylhydroxypyridine succinate or actovegin).The efficacy of therapy was assessed using standardized scales of HAMD-17, HARS, CGI-S and CGI-I; the level of cognitive activity is on the MMSE scale, a 10-word memorization test and a mute clock drawing test.

Results: The rate of therapeutic response and the overall effectiveness were significantly higher in elderly depressive patients with complex therapy. In this group, the proportion of responders by the 28th day of therapy was 2 times higher (81.5 % versus 40.5 % with p < 0.0001) than in the group with monotherapy. By the end of treatment in the group with complex therapy, the change in the average total score HAMD-17 was 76.3 % in comparison with 63.1% (p < 0.0001) in the group with monotherapy, and the share of complete remissions was 76.6% and 34.2 % respectively (p < 0.0001). In patients with complex therapy, there was also a faster improvement in cognitive functioning.

Conclusions: A new method of complex antidepressant therapy in combination with neuroprotective drugs allows achieving a faster and fuller therapeutic response and shortening hospitalization of patientswith late-life depressive.

CONTACT: saftatiana@mail.ru

References: 

1. Gavrilova S.I., Kaly`n Ya.B. Social`no-sredovy`e faktory` i sostoyanie psixicheskogo zdorov`ya pozhilogo naseleniya (kliniko-e`pidemiologicheskoe issledovanie) // Vestnik RAMN. – 2002. – № 9. – S. 15–20.

2. Baldwin R., Wild R. Management of depression in later life // Advances in Psychiatric Treatment. – 2004. – Vol. 10. – P. 131–139. – DOI: doi.org/10.1192/apt.10.2.131

3. Beekman A.T.F., Deeg D.J.H., Braam A.W., Smit J.H., Van Tilburg W. Consequences of major and minor depression in later life: a study of disability, well-being and service utilization // Psychological Medicine. – 1997. –Vol. 27. – P. 1397–1409. – DOI: doi.org/10.1017/s0033291797005734

4. Mosolov S.N. Klinicheskoe primenenie sovremenny`x antidepressantov. – SPb.: Medicinskoe informacionnoe agentstvo, 1995. – 568 s.

5. Hybels C.F., Blazer D.G., Steffens D.C. Predictors of partial remission in older patients treated for major depression: the role of comorbid dysthymia // Am J Geriatric Psychiatry. – 2005. – Vol. 13 (8) – P. 713–721.

6. Baldwin R.C., Gallagley A., Gourlay M., Jackson A., Burns A. Prognosis of late life depression: a three-year cohort study of outcome and potential predictors // Int J Geriatr Psychiatry. – 2006. – Vol. 21 (1). – P. 57–63. – DOI: doi.org/10.1002/gps.1424

7. Yakovleva O.B., Fedorov V.V., Ryaxovskij V.V. Isxody` depressij v pozdnem vozraste // Psixiatriya. – 2011. – Vol. 02 (50). – P. 5–12.

8. Sheehan B., Karim S., Burns A. Mood disorders. In: Old age psychiatry. – Oxford: Oxford University Press, 2009. – C. 95–124. – DOI: doi.org/10.1093/med/9780199216529.003.0004

9. Katona C., Livingston G. How well do antidepressants work in older people? A systematic review of Number Needed to Treat // Journal of Affective Disorders. – 2002. – Vol. 69 (1–3). – P. 47–52. – DOI: doi.org/10.1016/s0165-0327(00)00332-3

10. Van Straaten I. C. W., Scheltens P. Imaging abnormalities and depression in the elderly // Medicographia. – 2003. – Vol. 25. – P. 68–71.

11. Alexopoulos G.S. Frontostriatal and limbic dysfunction in late-life depression // American Journal of Geriatric Psychiatry. – 2002. – Vol. 10 (6). – P. 687–695. – DOI: doi.org/10.1176/appi.ajgp.10.6.687

12. Sexton C.E., Le Masurier M., Allan C.L., Jenkinson M., McDermott L., Kalu U.G., Herrmann L.L., Bradley K.M., Mackay C.E., Ebmeier K.P. Magnetic resonance imaging in late-life depression: vascular and glucocorticoid cascade hypotheses // The British Journal of Psychiatry. – 2012. –Vol. 201 (1). – P. 46–51. – DOI: doi.org/10.1192/bjp.bp.111.105361

13. Reppermund S., Zhuang L., Slavin M.J., Trollor J.N. at al. White matter integrity and late-life depression in community-dwelling individuals: diffusion tensor imaging study using tract-based spatial statistics // The British Journal of Psychiatry. – 2014. – Vol. 205 (4). – P. 315–320. – DOI: doi.org/10.1192/bjp.bp.113.142109

14. Yakovleva O.B. Kognitivny`e narusheniya v strukture e`ndogenny`x depressij pozdnego vozrasta // Zhurnal nevropatologii i psixiatrii imeni C.C. Korsakova. – 1995. – Vol. 95 (5). – P. 62–68.

15. Panza F., Frisardi V., Capurso C., D’Introno A. at al. Late-life depression, mild cognitive impairment, and dementia: possible continuum? // Am J Geriatr Psyhiatry. – 2010. – Vol. 18 (2). – P. 98–116. – DOI: doi.org /10.1097/JGP.0b013e3181b0fa13

16. Mitchell A.J., Subramaniam H. Prognosis of depression in old age compared to middle age: a systematic review of comparative studies // Am J of Psychiatry. – 2005. – Vol. 162. – P. 1588–1601. – DOI: doi.org/10.1097/JGP.0b013e3181b0fa13

17. Safarova T.P., Sheshenin V.S., Fedorov V.V. E`ffektivnost` psixofarmakoterapii u bol`ny`x gerontopsixiatricheskogo stacionara s funkcional`ny`mi psixicheskimi rasstrojstvami // Psixiatriya. – 2013. – № 1 (57). – S. 24–33.

18. Bonnie S. Wiese Geriatric depression: The use of antidepressants in the elderly // BCMJ. – 2011. – Vol. 53 (7). – P. 341–347.

19. Mosolov S.N. Sovremenny`e biologicheskie gipotezy` rekurrentnoj depressii (obzor) // Zhurnal nevrologii i psixiatrii imeni S.S. Korsakova. – 2012. – T. 112, № 11–2. – S. 29–40.

20. Sheline Y.I., Gado M.H., Kraemer H.C. Untreated depression and hippocampal volume loss // American Journal of Psychiatry. – 2003. – Vol. 160 (8). – P. 1516–1518. – DOI: doi.org/10.1176/appi.ajp.160.8.1516

21. Kays J.L., Hurley R.A., Taber K.H. The dynamic Brain: Neyroplasticity and Mental Health // The Journal of Neuropsychiatry and Clinical Neurosciences. – 2012. – Vol. 24 (2). – P. 118–124. – DOI: doi.org/10.1176/appi.neuropsych.12050109

22. Bennett M.R. The prefrontal-limbic network in depression: a core pathology of synapse regression // Progress Neurobiology. – 2011. – Vol. 93 (4). – P. 457–467. – DOI: doi.org/10.1016/j.pneurobio.2011.01.001

23. Frodl T., Jäger M., Smajstrlova I. et al. Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study // The Journal of Psychiatry Neuroscience. – 2008. – Vol. 33. – P. 423–430.

24. Malykhin N.V. Structural changes in the hippocampus in major depressive disorder: contributions of disease and treatment // The Journal of Psychiatry Neuroscience. – 2010. – Vol. 35 (5). – P. 337–343. – DOI: doi.org/10.1503/jpn.100002

25. Sairanen M. Brain-derived neurotrophic factor and antidepressant drug have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus // The Journal of Neuroscience. – 2005. – Vol. 25 (5). – P. 1089–1094. – DOI: doi.org/10.1523/jneurosci.3741-04.2005

26. Kaly`n Ya.B., Safarova T.P., Sheshenin V.S., Gavrilova S.I. Sravnitel`naya e`ffektivnost` i bezopasnost` antidepressivnoj mono- i mul`timodal`noj terapii u pozhily`x bol`ny`x depressiej (opy`t klinicheskogo primeneniya v gerontopsixiatricheskom stacionare) // Zhurnal nevrologii i psixiatrii imeni S.S. Korsakova. – 2014. – № 2 (6). – S. 20–29.

27. Gavrilova S.I., Kaly`n Ya.B., Safarova T.P., Yakovleva O.B., Sheshenin V.S., Kornilov V.V., Shipilova E.S. Optimizaciya antidepressivnoj terapii v usloviyax gerontopsixiatricheskogo stacionara // Zhurnal nevrologii i psixiatrii imeni S.S. Korsakova. – 2015. – Vol. 2 (6). – P. 46–54.

28. Kaly`n Ya B., Gavrilova S.I., Safarova T.P., Yakovleva O.B., Sheshenin V.S. Novy`e vozmozhnosti optimizacii terapii depressij v gerontopsixiatricheskoj praktike // Farmateka. – 2016. – Vol. 4 (16). – P. 46–54.

29. Safarova T.P., Yakovleva O.B., Sheshenin V.S., Kornilov V.V., Shipilova E.S. Novy`e puti optimizacii antidepressivnoj terapii pozhily`x depressivny`x bol`ny`x v usloviyax gerontopsixiatricheskogo stacionara // Psixiatriya. – 2017. – Vol. 3. – P. 5–13.

30. Safarova T.P., Yakovleva O.B., Sheshenin V.S., Gavrilova S.I. Metody` augmentacii antidepressivnoj terapii (na modeli kompleksnoj terapii s vklyucheniem aktovegina) u pozhily`x bol`ny`x gerontopsixiatricheskogo stacionara // Zhurnal nevrologii i psixiatrii imeni S.S. Korsakova. – 2018. – Vol. 2 (6). – P. 55–63.

31. Frank E. Conceptualization and rationale for consensus definitions of terms in major depressive disorder // Archives of General Psychiatry. – 1991. – Vol. 48 (9). – P. 851. – DOI: doi.org/10.1001/archpsyc.1991.01810330075011

32. Muresanu D.F. Neuromodulation with pleiotropic and multimodal drug – future approaches to treatment of neurological disorders // Acta Neurochirurgica Supplementum. – 2009. – Vol. 106. – P. 291–294. – DOI: doi.org/10.1007/978-3-211-98811-4_54

33. Rush J.A., Trivedi M.H., Wisniewski S.R. et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report // Am J Psychiatry. – 2006. – Vol. 163 (11). – P. 1905–1917. – DOI: doi.org/10.1176/appi.ajp.163.11.1905